Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
45 hedge funds and large institutions have $23.8M invested in Psychemedics Corporation in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 7 closing their positions.
2% less funds holding
Funds holding: 46 → 45 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
19% less capital invested
Capital invested by funds: $29.6M → $23.8M (-$5.74M)
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$264K |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$169K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$142K |
| 4 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$98.7K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
-$1.29M |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$982K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$425K |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$370K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$80.1K |
PMD Hedge Fund Activity: Q3 2019 in Review
45 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2019, worth a combined $23.8M — down 19% from $29.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PMD and 6 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 10 added.
The largest buyer was Renaissance Technologies, adding an estimated $264K. The largest seller was DePrince Race & Zollo Inc (DRZ), cutting an estimated $1.29M.
- 45 institutional investors held Psychemedics Corporation (PMD) as of Q3 2019, down from 46 in Q2 2019.
- Funds reported $23.8M of Psychemedics Corporation stock for Q3 2019, down 19% quarter-over-quarter.
- 6 funds opened new Psychemedics Corporation positions in Q3 2019 and 7 closed out, a net change of -1 holder.
- The largest Psychemedics Corporation buyer in Q3 2019 was Renaissance Technologies, an estimated $264K added.
- The largest Psychemedics Corporation seller in Q3 2019 was DePrince Race & Zollo Inc (DRZ), an estimated $1.29M sold.
Based on aggregated 13F filings for Q3 2019.